Loading...
B7-H3 targeted antibody-based immunotherapy of malignant diseases
INTRODUCTION: Recent advances in immuno-oncology and bioengineering have rekindled the interest in monoclonal antibody (mAb)-based immunotherapies for malignancies. Crucial for their success is the identification of tumor antigens (TAs) that can serve as targets. B7-H3, a member of the B7 ligand fam...
Saved in:
| Published in: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087627/ https://ncbi.nlm.nih.gov/pubmed/33301369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2021.1862791 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|